Frontiers in Medicine · Nov 16, 2026

Elevated Serum ICAM-1 and VCAM-1 Are Associated with Sarcopenia: A Cross-Sectional Study

By Bingxiao Yin, Huaqing Liu, Feng Jia

Background: Chronic low-grade inflammation and endothelial dysfunction are implicated in the pathogenesis of sarcopenia, yet specific biomarkers linking endothelial activation to muscle wasting remain underexplored. Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) are established soluble markers of endothelial inflammation. This study investigated whether elevated serum ICAM-1 and VCAM-1 levels are independently associated with sarcopenia in older adults. Methods: We conducted a cross-sectional study of 427 participants aged ≥65 years with complete data. Serum ICAM-1 and VCAM-1 concentrations were measured by enzyme-linked immunosorbent assay. Diagnostic utility was assessed via receiver operating characteristic (ROC) curve analysis, and associations were examined using multivariate logistic regression models adjusting for age, sex, BMI, Charlson Comorbidity Index, smoking, alcohol use, hypertension, serum albumin, and hemoglobin. Results: Sarcopenic participants exhibited significantly higher serum ICAM-1 (median 1,034.2 pg/mL, interquartile range [IQR] 555.9–1,647.0 vs. 825.2 pg/mL, IQR 442.7– 1,256.9; p = 0.005) and VCAM-1 (464.3 pg/mL, IQR 316.8–816.2 vs. 388.9 pg/mL, IQR 218.8–618.6; p = 0.010) levels compared with non-sarcopenic participants. ROC analysis demonstrated limited discriminative ability for sarcopenia (ICAM-1 AUROC = 0.608; VCAM-1 AUROC = 0.599). Exploratory cutoffs were identified (ICAM-1 ≥1584.41 pg/mL; VCAM-1 ≥796.59 pg/mL). Participants with high ICAM-1 had increased odds of sarcopenia (adjusted OR = 5.146, 95% CI: 2.624–10.091, p < 0.001), and similarly, those with high VCAM-1 had increased odds of sarcopenia (adjusted OR = 3.573, 95% CI: 1.839–6.834, p < 0.001). Both biomarkers were also associated with low handgrip strength and, for ICAM-1, low muscle mass. Conclusion: Elevated serum ICAM-1 and VCAM-1 are associated with sarcopenia in older adults, reflecting endothelial activation and inflammatory pathways underlying age-related muscle wasting.

The paperJournal siteBiomarkers

AgingResearch.News